dual PI3K/HDAC inhibitors (Chinese Academy of Medical Sciences and Peking Union Medical College)

N/A

Report date: 2025/01/26 18:33:49
NME

Base Information

Drug Namedual PI3K/HDAC inhibitors (Chinese Academy of Medical Sciences and Peking Union Medical College)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase alpha inhibitorsHistone deacetylase 1 degraders
TargetsHistone deacetylase 1Phosphatidylinositol 3 kinase alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChinese Academy Of Medical Science & Peking Union Medical College
China Registration ClassN/A

Develop Information

Active CompaniesChinese Academy Of Medical Science & Peking Union Medical College
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A